agerel
macular
degener
amd
lead
caus
irrevers
blind
industri
world
two
clinic
form
late
amd
fast
develop
exud
form
wet
amd
defin
choroid
neovascular
cnv
slowli
develop
atroph
form
known
geograph
atrophi
ga
dri
amd
wet
amd
character
subretin
extravas
neovessel
hemorrhag
photoreceptor
cell
layer
induc
photoreceptor
cell
loss
dri
amd
character
retin
pigment
epithelium
rpe
atrophi
photoreceptor
degener
wet
amd
dri
amd
complex
multifactori
event
age
environment
factor
smoke
histori
oxid
stress
recent
low
grade
inflamm
clearli
involv
cnv
dri
amd
pathogenesi
first
evid
innat
immun
play
amd
came
genet
studi
show
peopl
polymorph
complement
factor
h
cfh
increas
preval
amd
sinc
polymorph
complement
factor
b
cfb
cfi
link
amd
moreov
polymorph
gene
eye
specif
express
microglia
also
associ
amd
exact
role
polymorph
gene
amd
remain
howev
unknown
defici
mice
accumul
microglia
macrophag
subretin
space
observ
similarli
human
propos
mutat
gene
would
induc
recruit
monocytesmicroglia
subretin
space
eye
patient
amd
also
shown
mice
defici
gene
phagocytosi
cellular
debri
lipid
monocyt
subretin
space
import
drusen
format
photoreceptor
degener
final
mous
model
cnv
releas
vegf
monocyt
recruit
subretin
space
play
crucial
role
choroid
blood
vessel
growth
therefor
regul
monocyt
recruit
subretin
space
appear
involv
develop
wet
dri
amd
role
innat
immun
amd
demonstr
elev
plasma
level
activ
complement
factor
creactiv
protein
crp
marker
inflamm
recent
human
anim
studi
indic
adapt
immun
direct
toward
retina
andor
rpe
also
involv
wet
dri
amd
review
discuss
potenti
sourc
role
adapt
immun
respons
variou
process
lead
exud
atroph
form
amd
earli
autoantibodi
retin
astrocyt
detect
serum
patient
amd
suggest
antiretin
autoantibodi
could
play
role
diseas
accordingli
use
indirect
immunohistochemistri
patel
colleagu
show
serum
peopl
agerel
maculopathi
arm
exhibit
higher
level
retin
autoantibodi
serum
control
autoantibodi
specif
layer
retina
autoantibodi
present
amd
patient
serum
mostli
associ
exud
form
amd
multipl
retin
autoantigen
describ
antiretin
antibodi
amd
patient
partli
react
unknown
retin
protein
vari
molecular
weight
includ
kda
neurofila
protein
found
photoreceptor
outer
segment
recent
studi
show
antiretin
antibodi
recogn
glial
fibrillari
protein
gfap
express
cell
astrocyt
retina
found
significantli
higher
level
amd
patient
blood
normal
control
patient
retin
diseas
use
antigen
microarray
techniqu
mohoroshi
colleagu
reveal
associ
form
amd
elev
serum
level
specif
autoantibodi
less
antigen
among
igg
igm
antiretin
autoantibodi
found
elev
level
serum
patient
amd
specif
phosphatidyl
serin
ps
elastin
cytochrom
c
collagen
iii
associ
specif
cnv
dri
amd
contrast
igg
igm
recogn
fibronectin
uniqu
associ
dri
amd
studi
author
also
show
increas
level
autoantibodi
recogn
constitu
drusen
extracellular
matrix
bruch
membran
also
present
amd
patient
howev
anoth
studi
associ
amd
develop
antiretin
autoantibodi
variou
retin
antigen
specif
absenc
correl
autoantibodi
amd
studi
howev
could
due
limit
sampl
size
nevertheless
taken
collect
numer
studi
demonstr
presenc
autoantibodi
recogn
retin
rpe
protein
sera
amd
patient
strongli
suggest
play
role
amd
addit
specif
retin
rpe
protein
adjunct
gener
free
radicalinduc
oxid
also
recogn
autoantibodi
oxid
docosahexaeno
dha
contain
lipid
gener
carboxyethylpyrrol
cep
protein
adduct
immunocytochemistri
local
cep
outer
segment
photoreceptor
rod
rpe
mous
retina
demonstr
intens
cep
immunereact
photoreceptor
human
amd
donor
compar
healthi
human
retina
also
shown
cep
adductedprotein
abund
drusen
blood
amd
patient
normal
human
donor
moreov
sera
amd
patient
demonstr
higher
mean
titer
anticep
autoantibodi
control
among
individu
exhibit
cepantigen
specif
autoantibodi
level
mean
nonamd
control
amd
importantli
mice
immun
cepadduct
mous
serum
albumin
lead
appear
antibodi
specif
cep
induc
rpe
lesion
photoreceptor
degener
result
strongli
suggest
autoantibodi
specif
recogn
cepadduct
protein
link
amd
suscept
studi
look
specif
autoantibodi
signatur
amd
antip
andor
anticep
clear
candid
must
undertaken
use
biomark
diseas
remain
complic
task
due
two
main
reason
great
varieti
target
recogn
autoantibodi
multipl
ig
subtyp
present
serum
amd
patient
ii
certain
extent
ident
specif
antiretin
autoantibodi
found
sera
amd
patient
sera
control
sera
patient
suffer
ocular
nonocular
diseas
instanc
antibodi
associ
amd
also
cancer
associ
retinopathi
car
nonparaneoplast
autoimmun
retinopathi
npair
similarli
antibodi
specif
basic
structur
compon
multipl
heat
chock
protein
hsp
found
sera
amd
patient
also
sera
patient
uveiti
moreov
also
recogn
autoantibodi
multipl
sclerosi
cardiovascular
diseas
point
still
know
whether
autoantibodi
specif
part
amd
process
could
one
caus
diseas
signatur
factor
involv
amd
patholog
instanc
age
inde
known
autoantibodi
level
increas
toler
mechan
fail
age
phenomenon
call
immunosenesc
altern
autoantibodi
specif
retin
andor
rpe
antigen
could
induc
ocular
tissu
damag
occur
amd
support
hypothesi
report
laser
treatment
rabbit
eye
releas
ocular
antigen
circul
gener
product
antiretin
antibodi
observ
month
later
serum
anoth
possibl
antiretin
rpe
autoantibodi
footprint
etiolog
agent
associ
amd
possibl
discuss
last
chapter
review
independ
know
whether
antiretin
rpe
autoantibodi
preexist
amd
produc
reaction
ocular
tissu
damag
amd
start
autoantibodi
capac
particip
amd
evolut
group
extens
studi
role
antiretin
autoantibodi
sever
model
retin
degener
shown
autoantibodi
recoverin
kill
photoreceptor
vivo
moreov
demonstr
adopt
transfer
antiretin
autoantibodi
obtain
royal
colleg
surgeon
rc
rat
model
inherit
retin
degener
induc
disrupt
blood
retin
barrier
brb
upregul
attract
macrophag
retina
increas
level
photoreceptor
apoptosi
accordingli
recent
shown
wt
mice
immun
complex
igg
link
antigen
deposit
retina
led
robust
inflammatori
respons
activ
microglia
recruit
myeloid
cell
studi
suggest
immun
complex
may
contribut
sever
phenomena
observ
amd
pathogenesi
interact
igg
inflamm
photoreceptor
degener
observ
cours
amd
especi
dri
form
diseas
interestingli
mohoroshi
cowork
also
report
antibodi
patient
amd
particularli
cnv
augment
significantli
tube
format
endotheli
cell
cultiv
matrigel
vitro
indic
potenti
role
autoantibodi
wet
amd
also
conclus
studi
requir
definit
link
presenc
antiretin
rpe
autoantibodi
amd
develop
potenti
effect
antibodi
amd
summar
figur
similar
presenc
autoantibodi
amd
cell
accumul
observ
amd
ocular
tissu
blood
sampl
almost
year
ago
penfold
colleagu
detect
electron
light
microscopi
presenc
lymphocyt
eye
amd
patient
semin
observ
propos
lymphocyt
may
play
role
neovascular
atrophi
rpe
breakdown
bruch
membran
earli
late
stage
macular
degener
figur
recent
cell
observ
fluoresc
microscopi
choroid
frozen
section
eye
amd
patient
gene
protein
express
chemokin
chemotact
cell
augment
ocular
fluid
amd
patient
antigen
present
potenti
recruit
cell
eye
possibl
sinc
mhc
class
ii
express
observ
rpe
enhanc
microglia
age
amd
age
mice
mrna
level
sever
gene
specif
cell
cell
receptor
antigen
present
molecul
lymphocyt
chemotaxi
adhes
leucocyt
overexpress
rpechoroid
complex
retina
murin
model
light
induc
retin
degener
mild
cell
infiltr
well
increas
level
dendrit
cell
dc
express
mhc
class
ii
retina
also
observ
report
suggest
potenti
role
adapt
immun
particular
lymphocyt
pathogenesi
amd
mani
year
patholog
protect
role
recruit
lymphocyt
amd
remain
subject
debat
howev
shown
polymorph
mhc
class
ii
molecul
influenc
develop
amd
suggest
cell
respons
might
inde
play
role
amd
patholog
hypothesi
confirm
recent
studi
faber
et
al
report
elev
percentag
memori
cell
blood
amd
patient
comparison
nonamd
control
higher
level
memori
cell
increas
time
risk
develop
amd
risk
amd
augment
time
case
person
enhanc
blood
level
memori
cell
exhibit
least
one
cfh
risk
allel
studi
indic
direct
cooper
effect
risk
factor
amd
outcom
clear
demonstr
cell
contribut
importantli
amd
pathogenesi
far
direct
studi
effect
lymphocyt
ocular
tissu
amd
howev
mani
lesson
drawn
observ
report
studi
experiment
autoimmun
uveiti
eau
eau
anim
serv
model
human
posterior
autoimmun
uveiti
eau
induc
mani
rodent
either
immun
retin
antigen
interphotoreceptor
retinoidbind
protein
irbp
mice
santigen
rat
adopt
transfer
uveitogen
cell
line
lymphocyt
essenti
induc
retin
destruct
human
anim
cell
deleteri
via
cell
death
induc
molecul
fasfasl
interact
granzymeperforin
product
mostli
secret
cytokin
retin
tissu
sever
year
ago
prototyp
cytokin
consid
import
explain
retin
destruct
uveiti
howev
recent
shown
lymphocyt
produc
particularli
involv
uveiti
therefor
import
studi
potenti
effect
amd
understand
role
cell
patholog
sever
subset
lymphocyt
distinguish
base
cytokin
produc
previous
involv
mani
inflammatori
autoimmun
diseas
includ
autoimmun
uveiti
particular
interest
rais
cell
either
th
tc
produc
amd
pathogenesi
kept
mind
also
secret
sever
cell
type
cell
nkt
cell
innat
lymphoid
cell
ilc
convent
cell
produc
seen
integr
global
autoimmun
process
involv
innat
adapt
immun
compon
disrupt
normal
retin
homeostasi
consequ
caus
amd
support
potenti
role
amd
increas
level
detect
serum
amd
patient
compar
level
sera
agematch
control
presenc
report
ocular
tissu
amd
patient
suggest
cell
involv
sever
patholog
process
observ
amd
addit
hasegawa
et
al
shown
produc
ilc
promot
experiment
intraocular
neovascular
laser
induc
cnv
mous
role
amd
definit
proven
studi
methyl
level
receptor
monocyt
isol
group
twin
one
sibl
present
sign
amd
one
dna
methyl
regul
gene
express
pattern
depend
environment
stimuli
inde
dna
methyl
mediat
silenc
gene
express
via
modif
chromatin
structur
thu
hypomethyl
gene
prone
express
methyl
one
lai
wei
et
al
show
frequenc
monocyt
express
receptor
superior
blood
sibl
amd
respect
sibl
without
amd
use
normal
control
report
methyl
level
receptor
monocyt
significantli
reduc
sibl
amd
comparison
respect
healthi
sibl
indic
receptor
express
induc
amd
addit
receptor
express
macula
patient
dri
wet
form
amd
nonamd
control
macula
mrna
protein
level
data
correl
strong
enough
suggest
interact
receptor
express
monocyt
blood
macula
could
play
role
amd
produc
cell
cell
type
would
involv
amd
evolut
via
sever
mechan
summar
figur
instanc
shown
abl
recruit
monocyt
activ
increas
phagocyt
capac
thu
potenti
enhanc
patholog
role
amd
similar
effect
report
neutrophil
also
neurotox
thu
could
particip
photoreceptor
destruct
moreov
experiment
autoimmun
enceph
model
multipl
sclerosi
observ
abl
breach
tight
junction
bloodbrain
barrier
vivo
accordingli
destruct
rpe
monolay
achiev
high
concentr
vitro
summari
could
key
player
form
amd
may
even
convert
one
form
inde
induc
destruct
photoreceptor
rpe
layer
observ
dri
form
amd
could
also
involv
wet
form
amd
sinc
shown
particip
vessel
growth
subretin
space
cnv
mous
therefor
good
candid
promot
cnv
exud
form
amd
either
directli
enhanc
growth
endotheli
cell
presenc
angiogen
factor
andor
indirectli
induc
product
vegf
cell
type
two
differ
mechan
least
could
explain
presenc
autoimmun
reaction
amd
oxid
stress
ii
infect
host
pathogen
figur
oxid
stress
recogn
one
major
risk
factor
develop
amd
link
oxid
stress
autoimmun
respons
could
happen
follow
immun
system
alarm
evolutionari
conserv
endogen
structur
term
damageassoci
molecular
pattern
damp
oxid
stress
common
sourc
tissu
cellular
injuri
also
potenti
sourc
damp
oxid
damag
mediat
reactiv
oxygen
speci
gener
deleteri
reactiv
aldehyd
byproduct
includ
carboxyethylpyrrol
cep
malondialdehyd
mda
advanc
glycat
end
age
product
carboxymethyllysin
cml
pentosidin
protein
modifi
aldehyd
adduct
mda
cep
adduct
becom
immunogen
exampl
alreadi
mention
mice
immun
cepadduct
protein
develop
cardin
featur
amd
age
macula
well
drusen
hallmark
amd
accumul
number
oxid
chemic
speci
includ
mda
pentosidin
cml
cep
therefor
oxid
lipid
protein
could
induc
gener
new
autoantigen
immun
system
toler
autoreact
cell
recogn
neoantigen
damp
could
provid
help
autoreact
b
cell
secret
autoantibodi
recogn
larg
spectrum
retin
rpe
antigen
modifi
oxid
byproduct
oxid
stress
could
thu
initi
autoimmun
type
respons
lead
amd
figur
altern
autoantibodi
autoimmun
cell
observ
amd
could
gener
follow
exposur
pathogen
instanc
infect
virus
bacteria
figur
previous
report
autoimmun
type
reaction
induc
follow
infect
sinc
amd
share
sever
featur
autoimmun
diseas
could
propos
infect
could
origin
amd
histor
eye
known
immun
privileg
site
protect
deleteri
immun
respons
howev
clear
eye
abl
elicit
immun
respons
need
instanc
respond
viral
infect
follow
elimin
pathogen
eye
autospecif
immun
may
aris
destroy
ocular
tissu
variou
mechan
exist
includ
molecular
mimicri
bystand
activ
epitop
spread
dual
reactiv
b
cell
could
explain
specif
antibacteri
viral
respons
turn
rpe
andor
retin
tissu
molecular
mimicri
studi
mechan
propos
explain
occurr
mani
autoimmun
diseas
includ
multipl
sclerosi
rheumatoid
arthriti
system
lupu
erythemat
molecular
mimicri
may
also
occur
ocular
tissu
infect
pathogen
contain
antigen
close
relat
selfantigen
present
retina
andor
rpe
induc
amd
inde
shown
suscept
strain
mice
follow
ocular
infect
mhv
viral
particl
rapidli
clear
eye
howev
week
retin
degener
occur
associ
presenc
autoantibodi
specif
retin
rpe
antigen
far
howev
associ
amd
infect
pathogen
scarc
inconsist
one
studi
amd
associ
elev
serum
igg
titer
specif
chlamydia
pneumonia
howev
refut
miller
et
al
contrast
author
show
associ
wet
amd
igg
titer
cytomegaloviru
cmv
small
sampl
size
studi
environment
host
factor
hla
cfh
polymorph
also
involv
amd
difficult
definit
link
one
pathogen
amd
altern
autoimmunelik
respons
observ
amd
could
induc
infect
sever
pathogen
host
encount
entir
life
concept
call
total
pathogen
burden
hypothesi
prior
infect
multipl
pathogen
carri
risk
infect
singl
pathogen
propos
explain
elev
level
crp
coronari
arteri
diseas
accordingli
taken
togeth
sum
plasma
level
igg
cmv
chlamydia
pneumonia
helicobact
pylori
correl
wet
form
amd
therefor
notion
total
pathogen
burden
may
prove
use
futur
better
understand
patholog
amd
may
provid
new
biomark
therapeut
strategi
diseas
summari
addit
inflamm
clearli
involv
amd
pathogenesi
seen
adapt
immun
also
probabl
play
diseas
autoantibodi
present
sera
amd
patient
specif
ps
cep
adduct
cell
either
produc
could
play
role
pathogenesi
amd
retin
age
modifi
metabol
equilibrium
retina
rpe
directli
destroy
retin
rpe
cell
express
autoantigen
concern
autoantibodi
despit
statist
signific
associ
presenc
arm
ie
earli
stage
amd
cnv
ga
role
amd
remain
subject
debat
studi
need
determin
exact
role
diseas
evolut
data
report
herein
clearli
suggest
elev
level
sera
ocular
tissu
amd
patient
involv
amd
pathogenesi
knowledg
amd
probabl
due
autoimmun
respons
mediat
least
partli
produc
cell
may
provid
new
therapeut
target
treatment
diseas
instanc
cell
recruit
cn
across
bloodretina
barrier
via
sever
chemokinechemokin
receptor
axe
produc
cell
report
express
mainli
target
chemokin
receptor
cours
amd
may
prove
benefici
patient
antibodi
secukinumab
ixekizumab
phase
ii
trial
treatment
rheumatoid
arthriti
result
trial
prove
use
regard
novel
strategi
amd
therapeut
approach
addit
detect
specif
autoantibodi
andor
cell
relat
molecul
may
serv
earli
biomark
amd
allow
treatment
start
irrevers
ocular
tissu
damag
occur
possibl
implic
oxid
stress
andor
infect
induc
autoimmun
type
reaction
may
also
open
new
perspect
understand
treatment
amd
benefici
effect
antioxid
strategi
observ
amd
could
therefor
explain
reduct
direct
tissu
damag
induc
free
radic
also
reduc
product
neoantigen
lead
activ
immun
system
ocular
tissu
altogeth
evid
present
suggest
autoimmun
one
main
risk
factor
amd
therefor
futur
instead
agerel
macular
degener
three
letter
may
stand
autoimmun
macular
diseas
